Lewis K - Search Results

1

Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.

Fasser D, Lewis K, Leslie C, Cull G, Radeski D, Augustson B, Howman R, Joske D, Crawford J, Grove C, Cheah CY. Fasser D, et al. Among authors: lewis k. Leuk Lymphoma. 2024 Oct 18:1-4. doi: 10.1080/10428194.2024.2416563. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39421976 No abstract available.

2

Event free survival at 12 months (EFS12) in stage 1 DLBCL - a reassuring milestone?

Lewis KL, Cheah CY. Lewis KL, et al. Leuk Lymphoma. 2020 Nov;61(11):2542-2543. doi: 10.1080/10428194.2020.1808214. Epub 2020 Aug 19. Leuk Lymphoma. 2020. PMID: 32812823 No abstract available.

3

The value of bispecific antibodies in relapsed and refractory DLBCL.

Lewis KL, Cheah CY. Lewis KL, et al. Leuk Lymphoma. 2024 Jun;65(6):720-735. doi: 10.1080/10428194.2024.2323085. Epub 2024 Mar 7. Leuk Lymphoma. 2024. PMID: 38454535 Review.

4

Refractory α/β-Hepatosplenic T-cell Lymphoma With Secondary CNS Dissemination and Severe Morbidity Related to Intrathecal Chemotherapy: A Case Report and Literature Review.

Lewis KL, Spagnolo D, Radeski D, Cheah CY. Lewis KL, et al. Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e564-e567. doi: 10.1016/j.clml.2019.05.014. Epub 2019 May 29. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31362868 Review. No abstract available.

5

Non-Covalent BTK Inhibitors-The New BTKids on the Block for B-Cell Malignancies.

Lewis KL, Cheah CY. Lewis KL, et al. J Pers Med. 2021 Aug 3;11(8):764. doi: 10.3390/jpm11080764. J Pers Med. 2021. PMID: 34442408 Free PMC article. Review.

6

About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

Lewis KL, Cheah CY. Lewis KL, et al. Expert Rev Hematol. 2022 Nov;15(11):959-962. doi: 10.1080/17474086.2022.2140138. Epub 2022 Oct 27. Expert Rev Hematol. 2022. PMID: 36278876 No abstract available.

7

Chimeric antigen receptor T-cell therapy for mantle cell lymphoma with central nervous system involvement: Progress, but not perfect.

Lewis KL, Cheah CY. Lewis KL, et al. Br J Haematol. 2023 Dec;203(5):701-703. doi: 10.1111/bjh.19095. Epub 2023 Sep 24. Br J Haematol. 2023. PMID: 37743427 No abstract available.

8

New Directions for Mantle Cell Lymphoma in 2022.

Kumar A, Eyre TA, Lewis KL, Thompson MC, Cheah CY. Kumar A, et al. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-15. doi: 10.1200/EDBK_349509. Am Soc Clin Oncol Educ Book. 2022. PMID: 35561299 Free article.

9

Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study.

Goh Z, Latimer M, Lewis KL, Cheah CY, Ciaccio PD, Cushion T, Hawkes EA, Harrop S, Ku M, Campbell A, Hamad N, Wood EM, Chung E, Chen PY, Cochrane T. Goh Z, et al. Clin Lymphoma Myeloma Leuk. 2023 May;23(5):370-378. doi: 10.1016/j.clml.2023.01.014. Epub 2023 Feb 1. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36804727

10

Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience.

Lewis KL, Chin CK, Manos K, Casey J, Hamad N, Crawford J, Ho SJ, Issa S, Grigg A, Wood P, Gandhi MK, Do B, Nastoupil L, Hawkes EA, Cheah CY. Lewis KL, et al. Br J Haematol. 2021 Mar;192(6):1049-1053. doi: 10.1111/bjh.16946. Epub 2020 Jul 16. Br J Haematol. 2021. PMID: 32677095 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,557 results

Search Page

Filters